401 related articles for article (PubMed ID: 33426092)
21. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
[TBL] [Abstract][Full Text] [Related]
22. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
Sung N; Khan SA; Yiu ME; Jubiz G; Salazar MD; Skariah A; Dambaeva S; Kwak-Kim J
J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
[TBL] [Abstract][Full Text] [Related]
23. Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3.
Rogenhofer N; von Schönfeldt V; Ochsenkühn R; Sili F; Thaler CJ
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():161-7. PubMed ID: 26407335
[TBL] [Abstract][Full Text] [Related]
24. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities.
Kiprov DD; Nachtigall RD; Weaver RC; Jacobson A; Main EK; Garovoy MR
Am J Reprod Immunol; 1996 Oct; 36(4):228-34. PubMed ID: 8911631
[TBL] [Abstract][Full Text] [Related]
25. [Application of intravenous immunoglobulin therapy (IVIG) in pregnant patients with recurrent spontaneous abortions].
Sipak-Szmigiel O; Ronin-Walknowska E; Mikłaszwicz A
Ginekol Pol; 2003 May; 74(5):350-5. PubMed ID: 12931461
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
Jafarzadeh S; Ahmadi M; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Kamrani A; Behrad B; Roshangar L; Jadidi-Niaragh F; Yousefi B; Mehdipour M; Farzadi L; Yousefi M
J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
[TBL] [Abstract][Full Text] [Related]
27. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
[TBL] [Abstract][Full Text] [Related]
29. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
Kwak JY; Kwak FM; Ainbinder SW; Ruiz AM; Beer AE
Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
[TBL] [Abstract][Full Text] [Related]
30. Systemic Characterization of Novel Immune Cell Phenotypes in Recurrent Pregnancy Loss.
Liu H; Lin XX; Huang XB; Huang DH; Song S; Chen YJ; Tang J; Tao D; Yin ZN; Mor G; Liao AH
Front Immunol; 2021; 12():657552. PubMed ID: 34122414
[TBL] [Abstract][Full Text] [Related]
31. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion.
Muyayalo KP; Li ZH; Mor G; Liao AH
Am J Reprod Immunol; 2018 Oct; 80(4):e13018. PubMed ID: 29984444
[TBL] [Abstract][Full Text] [Related]
32. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
[TBL] [Abstract][Full Text] [Related]
33. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.
Kotlan B; Padanyi A; Batorfi J; Fulop V; Szigetvari I; Rajczy K; Penzes M; Gyodi E; Reti M; Petranyi G
Am J Reprod Immunol; 2006 May; 55(5):331-40. PubMed ID: 16635207
[TBL] [Abstract][Full Text] [Related]
34. Recurrent pregnancy loss: a disease of inflammation and coagulation.
Kwak-Kim J; Yang KM; Gilman-Sachs A
J Obstet Gynaecol Res; 2009 Aug; 35(4):609-22. PubMed ID: 19751318
[TBL] [Abstract][Full Text] [Related]
35. [Intravenous immunoglobulin treatment of recurrent spontaneous abortion with immunopathological background].
Bátorfi J; Kotlán B; Padányi A; Réti M; Gyódi E; Rajczy K; Miklós K; Németh J; Melicher F; Vályi-Nagy I; Petrányi G; Fülöp V
Orv Hetil; 2005 Nov; 146(45):2297-302. PubMed ID: 16304808
[TBL] [Abstract][Full Text] [Related]
36. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis.
Wang SW; Zhong SY; Lou LJ; Hu ZF; Sun HY; Zhu HY
Reprod Biomed Online; 2016 Dec; 33(6):720-736. PubMed ID: 27720163
[TBL] [Abstract][Full Text] [Related]
37. A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.
Ensom MH; Stephenson MD
Hum Reprod; 2011 Sep; 26(9):2283-8. PubMed ID: 21771770
[TBL] [Abstract][Full Text] [Related]
38. Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions.
Graphou O; Chioti A; Pantazi A; Tsukoura C; Kontopoulou V; Guorgiadou E; Balafoutas C; Koussoulakos S; Margaritis LH; Varla-Leftherioti M
Am J Reprod Immunol; 2003 Jan; 49(1):21-9. PubMed ID: 12733591
[TBL] [Abstract][Full Text] [Related]
39. Intravenous immunoglobulin in the prevention of recurrent miscarriage: does it work?
Christiansen OB; Nielsen HS
Chem Immunol Allergy; 2005; 88():117-127. PubMed ID: 16129941
[TBL] [Abstract][Full Text] [Related]
40. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
